Validation of the Spanish Version of the Clinically Useful Depression Outcome Scale (CUDOS) Scale

NCT ID: NCT01360307

Last Updated: 2011-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

330 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-06-30

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Clinically Useful Depression Outcome Scale (CUDOS) is a brief, self-administered instrument that not only evaluates depressive symptoms but also both functioning and quality of life. The assessment of patients´ perspective may provide valuable information that could be lost if relaying only on clinician evaluation. The purpose of this study is to achieve a psychometric validation into Spanish of the CUDOS scale in patients with major depression disorder in a primary care setting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Unipolar Depression

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

psychometric validation major depressive disorder patient-reported outcome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Major Depressive Disorder Patients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major depression disorder diagnosis according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) criteria in the last 3 months
* Major depression disorder diagnosis according to Prime-MD criteria in the last 3 months

Exclusion Criteria

* Be unable to understand and comply with the study requirements as judged by the investigator
* Participation in another trial prior to enrolment into this study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

A Coruña, , Spain

Site Status

Research Site

Barcelona, , Spain

Site Status

Research Site

Cadiz, , Spain

Site Status

Research Site

Córdoba, , Spain

Site Status

Research Site

El Vendrell, , Spain

Site Status

Research Site

Granada, , Spain

Site Status

Research Site

Huelva, , Spain

Site Status

Research Site

Lugo, , Spain

Site Status

Research Site

Madrid, , Spain

Site Status

Research Site

Majadahonda, , Spain

Site Status

Research Site

Málaga, , Spain

Site Status

Research Site

Nigrán, , Spain

Site Status

Research Site

Palma Mallorca, , Spain

Site Status

Research Site

Salamanca, , Spain

Site Status

Research Site

Terrassa, , Spain

Site Status

Research Site

Tudela, , Spain

Site Status

Research Site

Vigo, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-NES-XXX-2011/1

Identifier Type: -

Identifier Source: org_study_id